Abstract
Mesenchymal stem cells (MSC) represents a heterogeneous group of multipotent non-hematopoietic stem cells with self-renewal and differentiating into mesenchymal cell lineage. Recent studies have demonstrated that MSC has low immunogenicity, which means it does not express major histocompatibility complex (MHC) class Ⅱand other co-stimulating factors. Thus, due to the capability of anti-inflammatory and immunomodulatory effects, MSC therapy provides many possibilities for the treatment for immune skin diseases.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
